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Background
The use of halogenated anaesthetics in cardiac surgery is
still controversial. Preconditioning and postconditioning
are the well described mechanisms that explain the pro-
tective myocardial effect of specific drugs in order to
prevent the occurrence and/or to reduce the size of a
necrotic post-ischemic myocardial area [1]: they play a
well recognized role in the “protective effect” of the
halogenated anaesthetics. Preconditioning and postcon-
ditioning protect the myocardial cell from oxidative
stress and take place through the activation of specific
receptors and second messengers systems [2]. Desflur-
ane has shown a higher preconditioning and postcondi-
tioning power that could be optimal at 6% of Minimum
Alveolar Concentration (MAC) [3]. The solubility of the
halogenated anaesthetics can be altered during cardiac
surgery: Desflurane has shown a rapid wash-in and
wash-out profile in cardiac “on pump” surgery [5,6].
Conclusions
Halogenated anaesthetics and especially desflurane pro-
tect myocardium from the peri-operative ischemic injury
even in case of high risk elderly patients [7].
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